Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 38% ± 23% | |
goblet cell | 4 studies | 26% ± 7% | |
GABAergic neuron | 4 studies | 41% ± 22% | |
astrocyte | 3 studies | 43% ± 17% | |
interneuron | 3 studies | 54% ± 21% | |
oligodendrocyte precursor cell | 3 studies | 31% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 40% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 95% | 5076.35 | 340 / 359 | 95% | 49.35 | 272 / 286 |
intestine | 85% | 745.46 | 820 / 966 | 93% | 36.21 | 492 / 527 |
brain | 98% | 353.74 | 2602 / 2642 | 62% | 4.33 | 440 / 705 |
ovary | 97% | 275.05 | 175 / 180 | 54% | 6.24 | 231 / 430 |
prostate | 89% | 431.49 | 219 / 245 | 61% | 6.98 | 308 / 502 |
breast | 57% | 200.98 | 260 / 459 | 53% | 6.77 | 593 / 1118 |
lung | 48% | 103.48 | 277 / 578 | 59% | 10.74 | 685 / 1155 |
uterus | 68% | 304.31 | 115 / 170 | 31% | 11.21 | 144 / 459 |
esophagus | 42% | 68.82 | 614 / 1445 | 56% | 34.60 | 103 / 183 |
pancreas | 4% | 5.35 | 12 / 328 | 89% | 34.94 | 159 / 178 |
skin | 66% | 199.95 | 1193 / 1809 | 24% | 2.15 | 113 / 472 |
adrenal gland | 62% | 100.94 | 161 / 258 | 8% | 0.54 | 19 / 230 |
kidney | 49% | 117.99 | 44 / 89 | 15% | 2.46 | 137 / 901 |
bladder | 10% | 14.10 | 2 / 21 | 43% | 9.96 | 219 / 504 |
blood vessel | 49% | 107.18 | 654 / 1335 | 0% | 0 | 0 / 0 |
muscle | 48% | 134.28 | 388 / 803 | 0% | 0 | 0 / 0 |
adipose | 42% | 164.54 | 508 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 2.32 | 10 / 29 |
eye | 0% | 0 | 0 / 0 | 23% | 1.37 | 18 / 80 |
tonsil | 0% | 0 | 0 / 0 | 20% | 3.83 | 9 / 45 |
heart | 10% | 14.48 | 87 / 861 | 0% | 0 | 0 / 0 |
thymus | 2% | 2.40 | 16 / 653 | 8% | 0.47 | 46 / 605 |
liver | 0% | 0.44 | 1 / 226 | 10% | 2.56 | 39 / 406 |
peripheral blood | 1% | 2.65 | 10 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0061572 | Biological process | actin filament bundle organization |
GO_1900158 | Biological process | negative regulation of bone mineralization involved in bone maturation |
GO_0048705 | Biological process | skeletal system morphogenesis |
GO_0061182 | Biological process | negative regulation of chondrocyte development |
GO_0032432 | Cellular component | actin filament bundle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0031005 | Molecular function | filamin binding |
Gene name | RFLNA |
Protein name | Refilin-A (Regulator of filamin protein A) (RefilinA) |
Synonyms | FAM101A |
Description | FUNCTION: Involved in the regulation of the perinuclear actin network and nuclear shape through interaction with filamins. Plays an essential role in actin cytoskeleton formation in developing cartilaginous cells. . |
Accessions | ENST00000338359.4 [Q6ZTI6-2] ENST00000324038.6 [Q6ZTI6-2] ENST00000546355.4 [Q6ZTI6-1] ENST00000389727.8 [Q6ZTI6-2] Q6ZTI6 |